ArticleFrontiers in immunology2025

Bryostatin enhances CD20 CAR-T therapy efficacy against B-cell lymphoma by overcoming trogocytosis-mediated antigen loss.

Xiaofeng Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.